India is emerging as a growing APIs (Active Pharmaceutical Ingredients) manufacturing hub across the globe. According to current research, over 20% of the world's pharmaceutical API demand is being fulfilled by the API manufacturers in India. We have more than 1,500 WHO-GMP compliant API producing plants here.

Large and reputed API producers like SNJ Labs are playing an integral role in offering high-quality and cost-effective API drug production in India and many other countries. They follow all the necessary global pharmaceutical standards ensuring that they turn out as trusted pharma partners.

These API manufacturers prioritize high-purity raw material selection, highly-skilled manufacturing team, innovative R&D technologies, and overall futuristic infrastructures. They prefer continuous improvement in their manufacturing and QC processes.

Many manufacturers are also growing API exporters as well. They have professional teams and robust networks around the world that enable them to ensure seamless API exporting. Because of their contribution, India is standing at approximately $50 billion USD in 2025. With the steadily growing demand in different healthcare areas, these numbers are only going to increase in the near future.

With the growing pharmaceutical market, pharma organizations worldwide are having a wide exposure to API manufacturers. This availability has shaped tough competition which encouraged the manufacturers to focus on more process innovation strategies, strict quality standards, as well as expenses optimization.

This competitive environment may seem troublesome for some, but ultimately, it has motivated the API producers to focus on better quality and reliable active pharmaceutical ingredients manufacturing. They can also improve their organization’s revenue generation through innovative and safe API production. This way, Indian API manufacturers are taking steps further in the global pharma market and establishing their customers across the world.

Overall, India’s contribution is inevitable in the world pharmaceutical industry. The API manufacturers are continuously putting effort into developing more and more effective, safe, and affordable APIs for a better well-being of people.